FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980916207> ?p ?o ?g. }

• W2980916207 endingPage "603" @default.
• W2980916207 startingPage "603" @default.
• W2980916207 abstract "α-Conotoxins (α-CTxs) are small disulfide-rich peptides from venom of Conus species that target nicotinic acetylcholine receptors (nAChRs). The muscle-type nAChRs have been recognized as a potential target for several diseases, such as myogenic disorders, muscle dystrophies, and myasthenia gravis. EI, an α4/7-CTx, mainly blocks α1β1δε nAChRs and has an extra N-terminal extension of three amino acids. In this study, the alanine scanning (Ala-scan) mutagenesis was applied in order to identify key residues of EI for binding with mouse α1β1δε nAChR. The Ala-substituted analogues were tested for their abilities of modulating muscle and neuronal nAChRs in Xenopus laevis oocytes using two-electrode voltage clamp (TEVC) recordings. Electrophysiological results indicated that the vital residues for functional activity of EI were His-7, Pro-8, Met-12, and Pro-15. These changes exhibited a significant decrease in potency of EI against mouse α1β1δε nAChR. Interestingly, replacing the critical serine (Ser) at position 13 with an alanine (Ala) residue resulted in a 2-fold increase in potency at the α1β1δε nAChR, and showed loss of activity on α3β2 and α3β4 nAChRs. Selectivity and potency of [S13A] EI was improved compared with wild-type EI (WT EI). In addition, the structure–activity relationship (SAR) of EI revealed that the “Arg1–Asn2–Hyp3” residues at the N-terminus conferred potency at the muscle-type nAChRs, and the deletion analogue △1–3 EI caused a total loss of activity at the α1β1δε nAChR. Circular dichroism (CD) spectroscopy studies demonstrated that activity loss of truncated analogue △1–3 EI for α1β1δε nAChR is attributed to disturbance of the secondary structure. In this report, an Ala-scan mutagenesis strategy is presented to identify crucial residues that are significantly affecting potency of E1 for mouse α1β1δε nAChR. It may also be important in remodeling of some novel ligands for inhibiting muscle-type nAChRs." @default.
• W2980916207 created "2019-10-25" @default.
• W2980916207 creator A5019188220 @default.
• W2980916207 creator A5021726541 @default.
• W2980916207 creator A5025925141 @default.
• W2980916207 creator A5033151110 @default.
• W2980916207 creator A5035785299 @default.
• W2980916207 creator A5046805275 @default.
• W2980916207 creator A5059296721 @default.
• W2980916207 creator A5065049243 @default.
• W2980916207 date "2019-10-16" @default.
• W2980916207 modified "2023-10-15" @default.
• W2980916207 title "Identification of Crucial Residues in α-Conotoxin EI Inhibiting Muscle Nicotinic Acetylcholine Receptor" @default.
• W2980916207 cites W1513183398 @default.
• W2980916207 cites W1524388726 @default.
• W2980916207 cites W1599390971 @default.
• W2980916207 cites W1830932628 @default.
• W2980916207 cites W1908865100 @default.
• W2980916207 cites W1964640805 @default.
• W2980916207 cites W1989479815 @default.
• W2980916207 cites W1990787844 @default.
• W2980916207 cites W1991175900 @default.
• W2980916207 cites W1991233263 @default.
• W2980916207 cites W2014591547 @default.
• W2980916207 cites W2023259110 @default.
• W2980916207 cites W2040945433 @default.
• W2980916207 cites W2052956415 @default.
• W2980916207 cites W2077053514 @default.
• W2980916207 cites W2077379034 @default.
• W2980916207 cites W2080613497 @default.
• W2980916207 cites W2087968966 @default.
• W2980916207 cites W2104838343 @default.
• W2980916207 cites W2107821143 @default.
• W2980916207 cites W2127327997 @default.
• W2980916207 cites W2132390947 @default.
• W2980916207 cites W2160386479 @default.
• W2980916207 cites W2161684706 @default.
• W2980916207 cites W2165998358 @default.
• W2980916207 cites W2334851456 @default.
• W2980916207 cites W2431475031 @default.
• W2980916207 cites W2610452594 @default.
• W2980916207 cites W2626663956 @default.
• W2980916207 cites W2626920341 @default.
• W2980916207 cites W2766618560 @default.
• W2980916207 cites W2783623502 @default.
• W2980916207 cites W2808703885 @default.
• W2980916207 cites W2905755315 @default.
• W2980916207 cites W4323874152 @default.
• W2980916207 doi "https://doi.org/10.3390/toxins11100603" @default.
• W2980916207 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6832962" @default.
• W2980916207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31623211" @default.
• W2980916207 hasPublicationYear "2019" @default.
• W2980916207 type Work @default.
• W2980916207 sameAs 2980916207 @default.
• W2980916207 citedByCount "7" @default.
• W2980916207 countsByYear W29809162072020 @default.
• W2980916207 countsByYear W29809162072021 @default.
• W2980916207 countsByYear W29809162072022 @default.
• W2980916207 countsByYear W29809162072023 @default.
• W2980916207 crossrefType "journal-article" @default.
• W2980916207 hasAuthorship W2980916207A5019188220 @default.
• W2980916207 hasAuthorship W2980916207A5021726541 @default.
• W2980916207 hasAuthorship W2980916207A5025925141 @default.
• W2980916207 hasAuthorship W2980916207A5033151110 @default.
• W2980916207 hasAuthorship W2980916207A5035785299 @default.
• W2980916207 hasAuthorship W2980916207A5046805275 @default.
• W2980916207 hasAuthorship W2980916207A5059296721 @default.
• W2980916207 hasAuthorship W2980916207A5065049243 @default.
• W2980916207 hasBestOaLocation W29809162071 @default.
• W2980916207 hasConcept C104317684 @default.
• W2980916207 hasConcept C12554922 @default.
• W2980916207 hasConcept C169760540 @default.
• W2980916207 hasConcept C170493617 @default.
• W2980916207 hasConcept C175234850 @default.
• W2980916207 hasConcept C185592680 @default.
• W2980916207 hasConcept C188987157 @default.
• W2980916207 hasConcept C202751555 @default.
• W2980916207 hasConcept C2777240379 @default.
• W2980916207 hasConcept C2779448229 @default.
• W2980916207 hasConcept C2779535977 @default.
• W2980916207 hasConcept C2779570518 @default.
• W2980916207 hasConcept C2779856020 @default.
• W2980916207 hasConcept C2909754679 @default.
• W2980916207 hasConcept C515207424 @default.
• W2980916207 hasConcept C55493867 @default.
• W2980916207 hasConcept C57992300 @default.
• W2980916207 hasConcept C80161118 @default.
• W2980916207 hasConcept C86803240 @default.
• W2980916207 hasConceptScore W2980916207C104317684 @default.
• W2980916207 hasConceptScore W2980916207C12554922 @default.
• W2980916207 hasConceptScore W2980916207C169760540 @default.
• W2980916207 hasConceptScore W2980916207C170493617 @default.
• W2980916207 hasConceptScore W2980916207C175234850 @default.
• W2980916207 hasConceptScore W2980916207C185592680 @default.
• W2980916207 hasConceptScore W2980916207C188987157 @default.
• W2980916207 hasConceptScore W2980916207C202751555 @default.
• W2980916207 hasConceptScore W2980916207C2777240379 @default.
• W2980916207 hasConceptScore W2980916207C2779448229 @default.

• next